Wednesday, February 10, 2010, 8:48am EST - Canadian Markets open in 42 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Arrhythmia Research Technology Inc. (HRT)

On Feb 9: 5.15 USD   0.00 (0.00%)  
MORE ON HRT
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ARRHYTHMIA RES TECH (AMEX:HRT) Delayed quote dataEdit
Last Trade: 5.15 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 5.09
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: N/A
Day's Range: N/A - N/A
52wk Range: 1.38 - 6.49
Volume: 0
Avg Vol (3m): 8,873.02
Market Cap: 13.78M
P/E (ttm): 50.00
EPS (ttm): 0.10
Div & Yield: N/A (N/A%)
Arrhythmia Research Technology Inc. (HRT)
1d  5d  3m  6m  1y  2y  5y  max 
 Add HRT to Portfolio   Download Data

HEADLINES
Arrhythmia Research Technology, Inc. Announces OEM Version of PREDICTOR(TM) SAECG Software
Marketwire (Mon, Feb 8)
Micron Products Announces ISO 13485:2003 Certification
Marketwire (Wed, Jan 20)
Arrhythmia Research Technology, Inc. Declares Cash Dividend
Marketwire (Tue, Jan 19)
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials
EDGAR Online Financials (Fri, Nov 6)
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Oct 30)
Arrhythmia Research Technology, Inc. Announces Results for Third Quarter 2009
Marketwire (Wed, Oct 28)
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Aug 4)
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Jul 31)
Arrhythmia Research Technology, Inc. Announces Results for Second Quarter 2009
Marketwire (Thu, Jul 30)
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, May 11)
More Headlines for HRT...

ANALYST
EPS Est (next year) (Dec-69) : N/A
EPS Est (in 2 years) (Dec-69) : N/A
Avg Rec (current)*: N/A
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Arrhythmia Research Technology, Inc. engages in the development and licensing of medical software, which acquires data and analyzes electrical impulses of the heart to detect and aid in the treatment of potentially lethal arrhythmias.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices